Area of research
Molecular Biology · Genetics
Research interest
Research interests include Cancer therapeutics and mechanisms, Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, and Lung Cancer Research Studies.
ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient–derived xenograft mouse models
Zilovertamab Vedotin Targeting of ROR1 as Therapy for Lymphoid Cancers
A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia
Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma
Combinations of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3Kdelta) Inhibitor GS–1101 (CAL-101) with Rituximab and/or Bendamustine Are Tolerable and Highly Active in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Results From a Phase I Study